SEC Form 4 · accession 0001437749-15-006256

Impax Laboratories, LLC · IPXL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Larry Hsu

Director

Period of report

Mar 25, 2015

Accepted (ET)

Mar 27, 2015 · 5:56 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001003642

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Mar 25, 2015	M	5,500	$9.85	A	214,897	I	By Spouse
Common Stock	Mar 25, 2015	M	20,000	$11.50	A	234,897	I	By Spouse
Common Stock	Mar 25, 2015	M	25,000	$11.40	A	259,897	I	By Spouse
Common Stock	Mar 25, 2015	M	23,000	$5.06	A	282,897	I	By Spouse
Common Stock	Mar 2, 2015	Z	254,417	$0.00	D	55,151	D
Common Stock	Mar 2, 2015	Z	254,417	$0.00	A	2,545,300	I	By the Hsu Family Trust

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Stock Option (Right-to-Buy)^F1	$9.85	Mar 25, 2015	M	5,500	D	—	May 3, 2015	Common Stock	5,500	I
Stock Option (Right-to-Buy)^F1	$11.50	Mar 25, 2015	M	20,000	D	—	May 3, 2015	Common Stock	20,000	I
Stock Option (Right-to-Buy)^F1	$11.40	Mar 25, 2015	M	25,000	D	—	May 3, 2015	Common Stock	25,000	I
Stock Option (Right-to-Buy)^F1	$5.06	Mar 25, 2015	M	23,000	D	—	May 3, 2015	Common Stock	23,000	I

Explanation of responses

F1100% of the shares subject to the option are fully vested and exercisable.

Remarks

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.